Top Biotechnology companies in Australia by Revenue

This ranking features the top 17 Biotechnology companies in Australia ranked by Revenue, totalling a Revenue of USD 15.88 B, for January 15, 2025.
#
Name
Revenue
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 14.69 B
June 30, 2024 USD 173.13 0.11%

Australia

2
USD 459.88 M
June 30, 2024 USD 2.14 0.82%

Australia

3
USD 338.23 M
Dec. 31, 2023 USD 15.47 4.25%

Australia

4
USD 114.39 M
June 30, 2024 USD 2.01 -0.68%

Australia

5
USD 103.36 M
June 30, 2024 USD 0.62 -2.68%

Australia

6
USD 68.80 M
June 30, 2024 USD 1.33 6.17%

Australia

7
USD 58.79 M
June 30, 2024 USD 7.32 6.16%

Australia

8
USD 14.71 M
June 30, 2024 USD 0.74 -1.40%

Australia

9
USD 7.67 M
June 30, 2024 USD 2.37 1.84%

Australia

10
USD 5.90 M
June 30, 2024 USD 1.58 -2.06%

Australia

11
USD 4.58 M
June 30, 2024 USD 3.66 3.57%

Australia

12
USD 3.27 M
June 30, 2024 USD 2.00 1.52%

Australia

13
USD 2.80 M
Dec. 31, 2023 USD 5.88 0.14%

Australia

14
USD 2.68 M
June 30, 2024 USD 3.31 -4.06%

Australia

15
USD 2.56 M
June 30, 2024 USD 1.93 -0.52%

Australia

16
USD 1.54 M
June 30, 2024 USD 1.53 1.32%

Australia

17
USD 124.67 K
June 30, 2024 USD 3.82 6.70%

Australia

Frequently Asked Questions
  • Which Biotechnology company in Australia has the highest Revenue ?

    The Biotechnology company in Australia with the highest Revenue is CSL Limited (ASX: CSL.AX) at USD 14.69 B.

  • Which Biotechnology company in Australia has the lowest Revenue ?

    The Biotechnology company in Australia with the lowest Revenue is Opthea Limited (NasdaqGS: OPT) at USD 124.67 K.